Capital CS Group LLC Takes $653,000 Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Capital CS Group LLC bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 1,633 shares of the biotechnology company's stock, valued at approximately $653,000. Axon Enterprise makes up about 0.8% of Capital CS Group LLC's investment portfolio, making the stock its 24th biggest position.

Several other institutional investors and hedge funds have also added to or reduced their stakes in AXON. Motley Fool Asset Management LLC increased its holdings in shares of Axon Enterprise by 238.7% in the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company's stock valued at $153,981,000 after buying an additional 346,838 shares in the last quarter. 1832 Asset Management L.P. purchased a new stake in shares of Axon Enterprise during the first quarter valued at $81,630,000. Vanguard Group Inc. boosted its position in shares of Axon Enterprise by 2.7% in the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company's stock valued at $2,547,878,000 after purchasing an additional 212,401 shares during the period. Goldman Sachs Group Inc. increased its stake in Axon Enterprise by 110.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 276,011 shares of the biotechnology company's stock worth $71,302,000 after purchasing an additional 144,568 shares in the last quarter. Finally, Swedbank AB acquired a new stake in Axon Enterprise during the 1st quarter worth about $39,923,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Robert W. Baird raised their target price on shares of Axon Enterprise from $360.00 to $400.00 and gave the stock an "outperform" rating in a report on Tuesday, September 10th. JMP Securities boosted their target price on shares of Axon Enterprise from $375.00 to $430.00 and gave the company an "outperform" rating in a research note on Thursday, September 12th. Bank of America began coverage on Axon Enterprise in a research report on Wednesday, July 17th. They issued a "buy" rating and a $380.00 target price for the company. Jefferies Financial Group started coverage on Axon Enterprise in a research note on Wednesday, July 17th. They issued a "buy" rating and a $385.00 price objective for the company. Finally, Northland Securities lifted their target price on Axon Enterprise from $330.00 to $365.00 and gave the company an "outperform" rating in a research note on Thursday, August 8th. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise has an average rating of "Moderate Buy" and an average target price of $365.38.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock traded up $6.75 during midday trading on Friday, hitting $421.80. The company had a trading volume of 612,225 shares, compared to its average volume of 536,524. Axon Enterprise, Inc. has a 1-year low of $192.63 and a 1-year high of $422.33. The business's 50 day simple moving average is $365.66 and its two-hundred day simple moving average is $323.47. The stock has a market cap of $31.83 billion, a PE ratio of 123.33, a P/E/G ratio of 10.84 and a beta of 0.94. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping analysts' consensus estimates of $1.02 by $0.18. The business had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The firm's revenue for the quarter was up 34.5% compared to the same quarter last year. During the same period last year, the business earned $0.80 earnings per share. As a group, equities analysts predict that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Julie A. Cullivan sold 900 shares of the firm's stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the transaction, the director now directly owns 3,653 shares of the company's stock, valued at approximately $1,291,445.09. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Axon Enterprise news, CEO Patrick W. Smith sold 75,000 shares of Axon Enterprise stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $356.53, for a total transaction of $26,739,750.00. Following the completion of the transaction, the chief executive officer now directly owns 2,970,366 shares of the company's stock, valued at approximately $1,059,024,589.98. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Julie A. Cullivan sold 900 shares of the stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $353.53, for a total transaction of $318,177.00. Following the sale, the director now owns 3,653 shares of the company's stock, valued at $1,291,445.09. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 370,172 shares of company stock valued at $136,562,182 over the last ninety days. 6.10% of the stock is owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.